Drugs Online |
 |
 | ||
|
Zurig Uloric |
|
| ||
Drugs Online » Prescription Drugs 17 » Zurig Uloric Febuxostat is used to treat gout. Gout is a type of arthritis in which uric acid a naturally occurring substance in the body builds up in the joints and causes sudden attacks of redness swelling pain and heat in one or more joints. Febuxostat is in a class of medications called xanthine oxidase inhibitors. It works by decreasing the amount of uric acid that is made in the body. Febuxostat is used to prevent gout attacks but not to treat them once they occur. Buy Zurig Uloric and other Prescription Drugs 17 products online at Medstore. Buy Online at Medstore - Click Here!
About Zurig Uloric: Product Type: Prescription Drugs 17 Zurig (Uloric Generic Febuxostat) Zurig (Uloric Generic Febuxostat) Uloric Generic Febuxostat 40mg 70 Tablets 40mg 140(2 x 70) Tablets 40mg 280(4 x 70) Tablets 80mg 70 Tablets 80mg 2 x 70 Tablets 80mg 4 x 70 Tablets Uloric Generic Febuxostat Zurig
View more Prescription Drugs 17 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
